The Japanese medical device maker cut its outlook to between ¥75 billion and ¥87 billion, taking into account progress up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results